Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Determine the index fund with the lowest retirement cost through a concise comparison to guide a cost-aware choice.
28,256 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Six months into 2026, Ford faces a rare stumble as a Japanese competitor outsells its flagship F-Series in the period...
Kinsale Capital is carving a niche in the specialty insurance market. This article breaks down why it might be a stro...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
Eli Lilly unveiled a direct-to-employer program for Zepbound, aiming to accelerate GLP-1 adoption and expand market s...
When a growth stock plunges by half, investors often panic. But a durable business model, strong margins, and a clear...
Ford bets on human experience to guide AI, tapping 350 veteran engineers to steer its technology push as recalls and ...
As the EV market accelerates, some memory-faded battery names may offer outsized upside. This article dives into how ...
Investors are buzzing as micron just delivered massive momentum for MU. This article breaks down what happened, why i...
London fintech Revolut eyes the U.S. market as it rides a $75 billion valuation and 75 million global customers into ...
SK hynix's IPO opened with fanfare but quickly cooled, echoing a SpaceX pattern. Investors are weighing whether the p...
Conflicts in the Persian Gulf threaten the region’s desalination network, risking drinking water supplies for million...